Reagents and Consumables Supply for Diagnostic Platforms

The contract ensures the ongoing supply of FDA-approved reagents, test cartridges, and disposable consumables specifically designed for molecular diagnostic platforms, supporting critical laboratory operations. It is issued under the Bureau of Infectious Disease & Laboratory Sciences in Massachusetts, with performance required at a location in Boston, 02108. The agreement is classified as a subcontract and does not specify any set-aside type, indicating it is open to eligible general contractors without targeted socioeconomic preferences. The NAICS code 325412 aligns with the manufacturing of in vitro diagnostic substances, reinforcing the technical nature of the supplies required. The contractual obligation extends through June 30, 2029, providing a long-term, stable procurement framework for essential diagnostic materials. There is no solicitation number listed, suggesting this is a directly awarded or ongoing contract rather than a competitive bid. The absence of point of contact details and specific agency office address information implies the operational management may be handled internally through established channels. Continuous compliance with FDA regulations for all supplied items is implicit, ensuring the materials meet stringent quality and safety standards for use in clinical and public health settings.